Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers I > Headlines for Isis Pharmaceuticals Inc. > News item |
Isis retained by Global Crown at overweight
Isis Pharmaceuticals Inc. was retained by Global Crown Capital analyst Kate Winkler at an overweight rating with a price target on the stock of $9 per share following its recent round of financing, which netted the company $48 million. Isis shares Wednesday were up $0.08, or 1.61%, at $5.05 on volume of 396,971 shares versus the three-month running average of 500,250 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.